Literature DB >> 20534859

Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan.

Kazushi Motomura1, Masaru Yokoyama, Hirotaka Ode, Hiromi Nakamura, Hiromi Mori, Tadahito Kanda, Tomoichiro Oka, Kazuhiko Katayama, Mamoru Noda, Tomoyuki Tanaka, Naokazu Takeda, Hironori Sato.   

Abstract

Norovirus GII/4 is a leading cause of acute viral gastroenteritis in humans. We examined here how the GII/4 virus evolves to generate and sustain new epidemics in humans, using 199 near-full-length GII/4 genome sequences and 11 genome segment clones from human stool specimens collected at 19 sites in Japan between May 2006 and February 2009. Phylogenetic studies demonstrated outbreaks of 7 monophyletic GII/4 subtypes, among which a single subtype, termed 2006b, had continually predominated. Phylogenetic-tree, bootscanning-plot, and informative-site analyses revealed that 4 of the 7 GII/4 subtypes were mosaics of recently prevalent GII/4 subtypes and 1 was made up of the GII/4 and GII/12 genotypes. Notably, single putative recombination breakpoints with the highest statistical significance were constantly located around the border of open reading frame 1 (ORF1) and ORF2 (P <or= 0.000001), suggesting outgrowth of specific recombinant viruses in the outbreaks. The GII/4 subtypes had many unique amino acids at the time of their outbreaks, especially in the N-term, 3A-like, and capsid proteins. Unique amino acids in the capsids were preferentially positioned on the outer surface loops of the protruding P2 domain and more abundant in the dominant subtypes. These findings suggest that intersubtype genome recombination at the ORF1/2 boundary region is a common mechanism that realizes independent and concurrent changes on the virion surface and in viral replication proteins for the persistence of norovirus GII/4 in human populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534859      PMCID: PMC2916515          DOI: 10.1128/JVI.02125-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

Review 1.  Noroviruses everywhere: has something changed?

Authors:  Mary K Estes; Bv Verkataram Prasad; Robert L Atmar
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

2.  Novel recombinant norovirus causing outbreaks of gastroenteritis in Santiago, Chile.

Authors:  Roberto Vidal; Patricia Roessler; Verónica Solari; Jimena Vollaire; Xi Jiang; David O Matson; Nora Mamani; Valeria Prado; Miguel L O'Ryan
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Characterisation of a novel recombination event in the norovirus polymerase gene.

Authors:  Allison Waters; Suzie Coughlan; William W Hall
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

4.  Translation termination reinitiation between open reading frame 1 (ORF1) and ORF2 enables capsid expression in a bovine norovirus without the need for production of viral subgenomic RNA.

Authors:  Christopher J McCormick; Omar Salim; Paul R Lambden; Ian N Clarke
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  Detection of a novel intergenogroup recombinant Norovirus from Kolkata, India.

Authors:  Mukti K Nayak; Ganesh Balasubramanian; Ganesh C Sahoo; Rittwika Bhattacharya; Jan Vinje; Nobumichi Kobayashi; Mamta Chawla Sarkar; Mihir K Bhattacharya; Triveni Krishnan
Journal:  Virology       Date:  2008-07-20       Impact factor: 3.616

6.  Norovirus mixed infection in an oyster-associated outbreak: an opportunity for recombination.

Authors:  S J Symes; I C Gunesekere; J A Marshall; P J Wright
Journal:  Arch Virol       Date:  2007-02-28       Impact factor: 2.574

7.  Structural basis for the receptor binding specificity of Norwalk virus.

Authors:  Weiming Bu; Aygun Mamedova; Ming Tan; Ming Xia; Xi Jiang; Rashmi S Hegde
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

8.  Structural basis for the recognition of blood group trisaccharides by norovirus.

Authors:  Sheng Cao; Zhiyong Lou; Ming Tan; Yutao Chen; Yijin Liu; Zhushan Zhang; Xuejun C Zhang; Xi Jiang; Xuemei Li; Zihe Rao
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

9.  Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus.

Authors:  Jae-Mun Choi; Anne M Hutson; Mary K Estes; B V Venkataram Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-02       Impact factor: 11.205

10.  Genetic analysis of noroviruses associated with fatalities in healthcare facilities.

Authors:  M Okada; T Tanaka; M Oseto; N Takeda; K Shinozaki
Journal:  Arch Virol       Date:  2006-03-09       Impact factor: 2.574

View more
  32 in total

1.  Characterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010.

Authors:  Sayaka Takanashi; Qiuhong Wang; Ning Chen; Quan Shen; Kwonil Jung; Zhenwen Zhang; Masaru Yokoyama; Lisa C Lindesmith; Ralph S Baric; Linda J Saif
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

2.  Circulation of intergenotype recombinant noroviruses GII.9/GII.6 from 2006 to 2011 in central Greece.

Authors:  I G A Ruether; D Tsakogiannis; Z Kyriakopoulou; T G Dimitriou; C Papamichail; C Gartzonika; S Leveidiotou-Stefanou; P Markoulatos
Journal:  Virus Genes       Date:  2013-10-20       Impact factor: 2.332

3.  Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; S Hannah Shirley; David Lee; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

Review 4.  Comprehensive review of human sapoviruses.

Authors:  Tomoichiro Oka; Qiuhong Wang; Kazuhiko Katayama; Linda J Saif
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

5.  Bioluminescent enzyme immunoassay for the detection of norovirus capsid antigen.

Authors:  Nozomi Sakamaki; Yoshiyuki Ohiro; Mitsuki Ito; Mitsuru Makinodan; Tsubasa Ohta; Wataru Suzuki; Susumu Takayasu; Harufumi Tsuge
Journal:  Clin Vaccine Immunol       Date:  2012-10-17

6.  Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens.

Authors:  A de Rougemont; N Ruvoen-Clouet; B Simon; M Estienney; C Elie-Caille; S Aho; P Pothier; J Le Pendu; W Boireau; G Belliot
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

7.  Epidemiology and molecular characteristics of norovirus GII.4 Sydney outbreaks in Taiwan, January 2012-December 2013.

Authors:  Fang-Tzy Wu; Hsieh-Cheng Chen; Catherine Yen; Ching-Yi Wu; Kazuhiko Katayama; YoungBin Park; Aron J Hall; Jan Vinjé; Jason C Huang; Ho-Sheng Wu
Journal:  J Med Virol       Date:  2015-05-06       Impact factor: 2.327

8.  Deletion of a 197-Amino-Acid Region in the N-Terminal Domain of Spike Protein Attenuates Porcine Epidemic Diarrhea Virus in Piglets.

Authors:  Yixuan Hou; Chun-Ming Lin; Masaru Yokoyama; Boyd L Yount; Douglas Marthaler; Arianna L Douglas; Shristi Ghimire; Yibin Qin; Ralph S Baric; Linda J Saif; Qiuhong Wang
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

9.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.